![CIRRUS 6000 CIRRUS 6000]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.100.56.file/ga_cropped_1.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.360.203.file/ga_cropped_1.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.768.432.file/ga_cropped_1.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.1024.576.file/ga_cropped_1.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.1280.720.file/ga_cropped_1.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original.image_file.1440.810.file/ga_cropped_1.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/ga_cropped_1.jpg/_jcr_content/renditions/original./ga_cropped_1.jpg"})
OCT CIRRUS
Kit de ferramentas para AMD e atrofia geográfica
Dê aos seus pacientes todas as oportunidades de acederem a uma nova era de tratamento e cuidados da AMD com Advanced RPE Analysis e ZEISS AngioPlex: o Kit de ferramentas para a AMD e atrofia geográfica do ZEISS CIRRUS.
A degeneração macular relacionada com a idade (AMD) é a principal causa de perda de visão grave e irreversível em pessoas com mais de 60 anos de idade, e a sua prevalência está a aumentar a um nível alarmante em todo o mundo. Os seus pacientes podem estar em risco. Estima-se que 196 milhões de pessoas tinham AMD em 2020, um número que subirá para 288 milhões até 2040. No entanto, 25% dos casos de AMD num contexto de cuidados primários de oftalmologia não são diagnosticados.1,2 Isto representa um aumento de mais de 46%. São 92 milhões de pessoas que podem estar em risco de perder a visão, e não têm ideia de que isto está sequer a acontecer. Podemos ajudar estas pessoas. Saiba utilizar a Advanced RPE Analysis e o AngioPlex® em conjunto como um Kit de ferramentas para a AMD e atrofia geográfica, para diagnosticar e tratar os seus pacientes com AMD.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.100.100.80,0,560,480.file/196-million.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.360.360.80,0,560,480.file/196-million.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/196-million.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/196-million.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/196-million.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/196-million.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/196-million.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/196-million.png"})
Estima-se que cerca de 196 milhões de pessoas em todo o mundo tivessem AMD em 2020.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.100.100.23,0,428,405.file/affect-central-vision_lrg.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.360.360.23,0,428,405.file/affect-central-vision_lrg.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/affect-central-vision_lrg.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/affect-central-vision_lrg.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/affect-central-vision_lrg.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/affect-central-vision_lrg.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/affect-central-vision_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/affect-central-vision_lrg.jpg"})
A AMD afeta a visão central. 92 milhões de pessoas adicionais podem estar em risco de perder a visão.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.100.100.80,0,560,480.file/60-plus.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.360.360.80,0,560,480.file/60-plus.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/60-plus.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/60-plus.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/60-plus.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/60-plus.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/60-plus.png/_jcr_content/renditions/original.image_file.480.480.80,0,560,480.file/60-plus.png"})
Os pacientes adultos com mais de 60 anos de idade têm um risco maior de desenvolver AMD.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.100.100.23,0,428,405.file/risk-factors_lrg.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.360.360.23,0,428,405.file/risk-factors_lrg.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/risk-factors_lrg.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/risk-factors_lrg.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/risk-factors_lrg.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/risk-factors_lrg.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/risk-factors_lrg.jpg/_jcr_content/renditions/original.image_file.405.405.23,0,428,405.file/risk-factors_lrg.jpg"})
O tabagismo, o historial familiar, uma dieta pouco saudável, o sedentarismo e a exposição ao sol são alguns dos fatores de risco para desenvolver AMD.
Uma nova era para a atrofia geográfica
O papel da OCT
![Advanced RPE Analysis Advanced RPE Analysis]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.100.56.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.360.203.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.768.432.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.1024.576.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.1031.580.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.1031.580.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/article-1-advanced-rpe-analysis/figure2-rpe_analysis_selection16_9.jpg/_jcr_content/renditions/original.image_file.1031.580.1,0,1032,580.file/figure2-rpe_analysis_selection16_9.jpg"})
Advanced RPE Analysis
Medição quantitativa e comparação de dados do historial
A Advanced RPE Analysis, disponível no OCT ZEISS CIRRUS, foi especificamente criada para ajudar os médicos a tratar a AMD não neovascular em todas as suas formas.
![AngioPlex AngioPlex]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.100.56.0,130,1341,886.file/article_2_figure_2-octa_report.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.360.203.0,130,1341,886.file/article_2_figure_2-octa_report.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.768.432.0,130,1341,886.file/article_2_figure_2-octa_report.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.1024.576.0,130,1341,886.file/article_2_figure_2-octa_report.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.1280.720.0,130,1341,886.file/article_2_figure_2-octa_report.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.1341.754.0,130,1341,886.file/article_2_figure_2-octa_report.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_2_figure_2-octa_report.png/_jcr_content/renditions/original.image_file.1341.754.0,130,1341,886.file/article_2_figure_2-octa_report.png"})
AngioPlex
Importância da deteção precoce da progressão
Os sistemas de angiografia por OCT (OCTA) como o ZEISS CIRRUS AngioPlex® continuam a expandir os limites da aquisição de imagens oculares, para que os médicos possam cuidar melhor destes pacientes.
![Um modelo de cuidados colaborativos Um modelo de cuidados colaborativos]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.100.56.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.360.203.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.768.432.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.1024.576.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.1280.720.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.1440.810.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/product-portfolio/oct-systems/cirrus-6000/images/article_3_table_1-amd_classification_table.png/_jcr_content/renditions/original.image_file.1920.1080.84,0,2157,1166.file/article_3_table_1-amd_classification_table.png"})
Um modelo de cuidados colaborativos
Otimizar os resultados dos pacientes
O OCT ZEISS CIRRUS, com a sua Advanced RPE Analysis e o AngioPlex®, pode ser a base utilizada pelos optometristas e oftalmologistas para detetar e monitorizar todas as formas de AMD.
Transferências
Entre em contacto connosco!
Serviços disponíveis
-
1
Wong, Wan Ling, et al. «Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.» The Lancet Global Health 2.2 (2014): e106-e116
-
2
Neely DC, Bray KJ, Huisingh CE, et al. Prevalence of undiagnosed age-related macular degeneration in primary eye care. JAMA Ophthalmol. 2017;135(6):570-5